Powered by Google Google ÜbersetzerGoogle Übersetzer
Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Latest Press Releases
View all
TimeHeadline
Just nowLeidos to help strengthen global IT operations for the U.S. Department of State under Evolve contract
Just nowBird Receives Inaugural Investment Grade Credit Rating
Just nowCytomX Therapeutics to Present at Upcoming June Investor Conferences
Just nowService Properties Trust to Present at Nareit’s REITweek 2026 Investor Conference on Wednesday, June 3rd
1m agoAnalytixInsight Inc. Announces Letter to Shareholders Concerning the May 29, 2026 Special Meeting
Compass Therapeutics, Inc. logo

Compass Therapeutics, Inc.

About

1.89USD+0.08 +4.42%
Closed • Updated at 12:34 GMT+00:00
Market Cap$340.37M
Volume3.81M
Beta0.61
RSI28.51
Health TechnologyPharmaceuticals: Major

Compass Therapeutics, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

May 5 2026
Compass Therapeutics Reports 2026 First Quarter Financial Results and Provides Corporate Update 
Apr 24 2026
Compass Therapeutics to Announce Topline Secondary Endpoints from the Phase 2/3 COMPANION-002 Study of Tovecimig in Patients with Biliary Tract Cancer
Mar 5 2026
Compass Therapeutics Reports 2025 Financial Results and Provides Corporate Update
Jan 6 2026
Compass Therapeutics Provides Corporate Update
Jan 5 2026
Compass Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Community Chat

Ask AI

6ix6ixAIEvents